Perfromance Wealth Partners’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Perfromance Wealth Partners's EW Position: Q3 2026 in Review
Perfromance Wealth Partners increased its Edwards Lifesciences (EW) stake by 47% in Q3 2026, buying an estimated $108K and bringing the position to 3,781 shares worth $326K. The position accounts for 0.01% of the portfolio, ranked #165.
Perfromance Wealth Partners first reported a position in EW in Q4 2021 and has held it in 20 quarters since. The position peaked at $1.44M in Q4 2021. 1,339 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Perfromance Wealth Partners held 3,781 shares of Edwards Lifesciences worth $326K as of Q3 2026.
- Perfromance Wealth Partners bought 1,215 Edwards Lifesciences shares in Q3 2026, an estimated $108K.
- Edwards Lifesciences made up 0.01% of Perfromance Wealth Partners's portfolio in Q3 2026, its #165 holding.
- Perfromance Wealth Partners first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 20 quarters since.
- Perfromance Wealth Partners's Edwards Lifesciences position peaked at $1.44M in Q4 2021.
- 1,339 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Perfromance Wealth Partners's 13F filing for Q3 2026, filed 12 Nov 2026.